Objective: The Cox maze procedure (CM) is safe and effective for all atrial fibrillation (AF) types. A recent randomized trial found alarming rates of pacemaker implantation (PMI) during hospitalization after CM. The purpose of this study was to assess the rate of PMI and its impact on outcomes after CM.
See Editorial Commentary page 147.
The Cox maze (CM) procedure has been performed for more than 25 years and its success when conducted in experienced hands, using either cut and sew technique or ablation devices with proven delivery of transmurality, is well-documented. [1] [2] [3] [4] [5] The CM procedure, performed appropriately, is also demonstrated to be very safe for all atrial fibrillation (AF) types and across operative risk groups. [6] [7] [8] [9] [10] One of the challenges when assessing the efficacy and safety of the procedure is the lack of standardization in the way the procedure is being performed in terms of ablation tools as well as the lesion set. This point is especially important when it comes to lesions applied to the right atrium, with lesion patterns and tissue handling that can lead to relatively high rates of pacemaker implantation (PMI) following the procedure. 11 There are other potential explanations for PMI that cannot be explained by technical variability, such as the fact that sinus node dysfunction is recognized to be highly associated with AF and the potential for remodeling of the sinus node tissue and function secondary to AF and antiarrhythmic therapy. [12] [13] [14] The diagnosis of sinus node dysfunction, whether temporary or not, is therefore not unusual after a successful CM procedure simply because a successful procedure would challenge the sinus node to activate the atria that can no longer fibrillate. Sinus node damage secondary to ablative damage during surgical ablation should be extremely rare in a well-performed procedure. However, conduction disturbances, such as atrioventricular block, can be the result of mismanagement of the lateral wall of the right atria or a lesion set that is not consistent with the CM procedure, together with the indexed concomitant procedure performed. 11 A recent Cardiothoracic Surgical Trials Network (CTSN) randomized trial found alarming rates of PMI during hospitalization after surgical ablation (23 of 133), especially in patients following what was defined by the authors as a CM procedure. 15 We were surprised by the unusual rate of PMI in that study and the potential implication on the decision-making associated with surgical ablation of AF. Therefore, we decided to assess our own outcomes, particularly to understand if there are factors, whether preoperative or operative, that may predispose some patients to PMI. In our center, the CM procedure III/IV is performed in a uniform way with regard to lesion set and energy source. 2, 16, 17 The purpose of this study was to assess the rate of inhospital PMI for CM III/IV patients in an experienced center, examine factors that may be associated with PMI in those patients, and compare PMI incidence with patients with AF who did not undergo surgical ablation. We also sought to investigate the potential impact of PMI on early patient outcomes and long-term success rate and survival.
METHODS
All patients who had a CM III/IV procedure 2, 16, 17 from 2005 to 2015 (N ¼ 739) with or without other cardiac procedures were included in this study sample. Patients were excluded if they had previous PMI before surgery (n ¼ 92). Data were collected prospectively before and after surgery in our comprehensive AF registry and with the Society of Thoracic Surgeons (STS) institutional database. 18 Data on rhythm status (24-hour Holter monitoring and electrocardiography), medications, interventions, and clinical events were collected at 3, 6, 9, 12, 18, and 24 months and then yearly after surgery. Rhythm status was defined according to Heart Rhythm Society guidelines as freedom from atrial arrhythmia >30 seconds without use of class I/III antiarrhythmic drugs (AAD). 19 Data on new PMI after surgery in the same surgical hospitalization was collected on all CM patients. This study was approved by our institutional review board (institutional review board no. 06.022 and 12.055), and patient consent was waived.
Surgical CM Procedure
All CM III/IV procedures were performed either using cryothermal energy alone (ATS CryoMaze, Medtronic, Minneapolis, Minn; or Frigitronics, CooperSurgical, Inc, Trumbull, Conn; and Cryo1, AtriCure, West Chester, Ohio) or a combination of bipolar radiofrequency (Isolator Synergy Bipolar Ablation System, AtriCure) and cryothermal energy. The lesion pattern in all cases adhered to the CM III/IV lesion set.
2,16,17

Statistical Analysis
All data analyses were performed with SPSS Version 17.0 (SPSS Inc., Chicago, Ill) and R version 3. In the group of patients with a history of atrial arrhythmia since 2011 who had a concomitant CM procedure (n ¼ 251) and patients without surgical ablation (n ¼ 415), propensity score matching was conducted to simulate randomization and improve balance on preoperative characteristics. 20, 21 This time frame was chosen because the STS database began collecting data on in-hospital PMI for all patients in 2011. The control group included all cardiac surgery patients since 2011 with a history of atrial arrhythmia who did not undergo any surgical ablation procedure. Propensity scores were estimated via a logistic model with the R MatchIt package and were matched between groups within a caliper of 0.25 propensity score standard deviations. The variables used to create the propensity score model were selected a priori based on clinical and theoretical relevance and included age, gender, body mass index, diabetes, hypertension, cerebrovascular disease, chronic pulmonary disease, peripheral vascular disease, ejection fraction, preoperative creatinine level, Euro-SCORE II, elective status, concomitant valve surgery, and concomitant CABG surgery. Most CM patients were matched to patients in the control group, those without surgical ablation, and balance was improved between the groups ( Figure E1 ). The 180 patients in each group remaining after propensity score matching were used for all outcome analyses comparing
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patients who had CM and those without surgical ablation, particularly to examine in-hospital incidence of PMI.
RESULTS
The study sample consisted of 739 patients who underwent the full CM procedure. The mean age was 63.4 AE 11.1 years and 238 patients were women (32%). The CM procedure was performed concomitant with other surgical procedures in 79% of patients and as a standalone procedure in 21% of patients.
Fifty-two patients (7.0%) had newly implanted pacemakers during the hospital stay after the CM procedure. The type of in-hospital PMI was dual-chamber in all of these patients and mean time between surgery and PMI was 9.3 AE 5.5 days (median [IQR] ¼ 8 [6] [7] [8] [9] [10] [11] days). The most common primary indication for PMI was sick sinus syndrome (67%), followed by complete heart block (23%) and sinus bradycardia (10%). Patients with inhospital PMI had lower body mass index (P ¼ .006), lower median duration of AF (P ¼ .047), were more likely to be women (P ¼ .011), and were less likely to have hypertension (P ¼ .017) than patients without in-hospital PMI (Table 1) . Otherwise, the patients with in-hospital PMI had similar preoperative characteristics as patients without in-hospital PMI. Patients who had 2 or more concomitant valve procedures had the highest total incidence of PMI (PMI ¼ 14%). In addition, the group of patients with in-hospital PMI were significantly less likely to have a stand-alone CM procedure compared with patients without in-hospital PMI (10% vs 22%, P ¼ .032).
In multivariable analyses (Table 2) , the only significant independent association with in-hospital PMI was type of surgical procedure (Wald ¼ 13.44, P ¼ .020), such that patients who had multiple concomitant valve procedures were at greater risk than other surgery categories. Compared with patients with multiple concomitant valve procedures, those with stand-alone CM procedures had 80% lower odds for in-hospital PMI, those with concomitant single-valve procedures had 57% lower odds, those with concomitant CABG surgery procedures had 89% lower odds, and those with concomitant CABG with valve surgery procedures had 73% lower odds.
Clinical Outcome
Patients with in-hospital PMI had similar incidence of STS-defined perioperative complications compared with patients without in-hospital PMI, including deep sternal wound infection (0% vs 0.1%, P >.999), stroke/transient ischemic attack (0% vs 0.9%, P >.999), prolonged ventilation >24 hours (12% vs 8%, P ¼ .428), pneumonia (2% vs 4%, P >.999), renal failure (2% vs 4%, P > .999), reoperation for bleeding (0% vs 3%, P ¼ .397), readmissions<30 days (8% vs 13%, P ¼ .386), and operative mortality <30 days (0% vs 2%, P ¼ .615). However, patients with in-hospital PMI had a longer median hospital LOS than patients without in-hospital PMI (12 [9] [10] [11] [12] [13] [14] [15] , and all concomitant procedure types compared with stand-alone procedures (P ¼ .048-P <.001) in a multivariable analysis. During follow-up, patients with an in-hospital PMI did not differ from patients without an in-hospital PMI on return to sinus rhythm off AAD at 6 months (73% vs 78%, P ¼ .515), 12 months (80% vs 85%, P ¼ .409), and 24 months (71% vs 80%, P ¼ .265; Figure 1 ). There was also no difference between patients receiving in-hospital PMI and those without in-hospital PMI on the proportion of patients who required cardioversions (23% vs 20%, P ¼ .569) or ablations (8% vs 6%, P ¼ .564) during a mean follow-up of 53 AE 36 months.
During follow-up, none of the patients with in-hospital PMI had an embolic stroke and only 12 patients without PMI had embolic strokes (0% vs 1.7%, P >.999). There was no significant difference in percentage of patients who remained on anticoagulation at 6 months (68% vs 52%, P ¼ .061), but more patients with in-hospital PMI were on anticoagulation at 12 months (50% vs 34%, P ¼ .042) and 24 months (50% vs 32%, P ¼ .041) after surgery compared with those without in-hospital PMI. However, most patients in both groups (with and without in-hospital PMI) who remained on anticoagulation had clinically appropriate indications (eg, mechanical valve, history of deep vein thrombosis, atrial arrhythmia recurrence) at 6 months (78% vs 77%, P ¼ .943), 12 months (65% vs 63%, P ¼ .871), and 24 months (87% vs 79%, P ¼ .736). Patients with in-hospital PMI also did not differ from patients without in-hospital PMI on survival up to 5 years after surgery (81.9% vs 88.9%, log-rank ¼ 2.8, P ¼ .093; Figure 2 ).
Pacemaker interrogation reports reviewed during followup indicated that for those with in-hospital PMI, 12 patients had return of intact conduction (ie, no longer pacemakerdependent), 28 patients had not returned to intact conduction, and 12 patients were unknown either because no interrogation reports were available or there was no description of conduction by the electrophysiologist.
Propensity Score-Matched Analyses
Before propensity score matching, the group of patients with concomitant CM surgery (n ¼ 251) differed from the patients with AF without surgical ablation (n ¼ 415) on many preoperative characteristics, including age (65 vs 69 years, P < .001), ejection fraction (55% vs 47%, P <.001), EuroSCORE II (3.9% vs 8.7%, P <.001), diabetes (16% vs 31%, P < .001), elective status (87% vs 57%, P < .001), valve procedures (84% vs 51%, P<.001), and CABG surgery (24% vs 37%, P ¼ .001). After propensity score matching to simulate randomization and balance covariates, 180 patients in the CM group were matched to 180 patients with AF without surgical ablation ( Figure E1 ). There were no significant differences between the groups after matching on any of the preoperative characteristics and the standardized differences were appropriate (Table 3 ). After matching, the incidence of inhospital PMI was similar in patients with AF who had concomitant CM and those who did not have surgical ablation (5% vs 4%, P ¼ .609). In a double robust analysis, addition of the CM procedure also was not associated with greater incidence of in-hospital PMI after controlling for the covariates included in the propensity score model (odds ratio 1.32, 95% confidence interval 0.45-3.85, P ¼ .612).
DISCUSSION
The results of this study indicate that in patients who undergo a CM III/IV procedure, the incidence of in-hospital PMI was low and was not associated with increased morbidity, inferior rhythm outcome, or differences in long-term survival. Evidence from our study shows that the incidence of in-hospital PMI after a CM procedure is considerably lower than recently reported. 15 When the CM procedure is performed, even concomitantly with more complicated multiple valve procedures, a very low incidence of atrioventricular (AV) block was documented, which is probably the result of surgical valve procedures and not with any of the lesions associated with the CM procedure. In addition, propensity score-matched analyses suggest that adding the CM procedure was not associated with excess in-hospital PMI risk. This result was found in patients with comparable preoperative characteristics. In recent years, there has been a growing interest in the rate of PMI following surgical ablation of AF, especially when a biatrial lesion set is performed. 11, 15 Two different reports based on the STS database recognized PMI following surgical ablation and reported slightly higher incidence following surgical ablation combined with mitral valve surgery, but no difference in the rate of postsurgical PMI was identified in stand-alone procedures when comparing surgical ablation performed on and off cardiopulmonary bypass, which probably indicates the same rates of PMI when a biatrial lesion set is performed. 22, 23 The International Society for Minimally Invasive Cardiothoracic Surgery consensus statement clearly showed no increase in the risk for PMI associated with concomitant surgical ablation. 24 PMI following any cardiac surgical procedures, especially in patients who underwent complex valve surgery, transcatheter aortic valve implantation, or in patients who are elderly, is not uncommon and is a well-accepted outcome among the medical community. [25] [26] [27] However, when it comes to surgical ablation procedures for AF, it is clearly emphasized by some as an especially negative outcome and is readily overstated. The questions to ask in future research are whether the incidence can be managed by implementing training and appropriate techniques and if PMI following surgical ablation is associated with inferior clinical outcome and rhythm control. In the present study, we found that at an experienced center, incidence of in-hospital PMI could be maintained at a low level, which was comparable to patients without surgical ablation for AF. In addition, for patients who underwent the CM III/IV procedure using standardized techniques, in-hospital PMI was not associated with inferior clinical or rhythm outcomes during follow-up.
The incidence of PMI following any surgical ablation is variable and is dependent on patient characteristics with regard to preoperative sinus node dysfunction and surgical technique and manipulation. However, it is also important to standardize the clinical indications for PMI. In our center, patients with postprocedural bradycardia are being paced and atrial electrocardiogram is being captured daily. Therefore, the decision is based on clinical data demonstrating no recovery of sinus node activity, clinically significant conduction blocks or delays, and sinus bradycardia. The impact of PMI should be examined carefully, and in the context of surgical ablation it should always be evaluated beyond the immediate increase in perioperative cost. Although LOS was longer for patients with in-hospital PMI, part of this increase was due to other important factors that would increase LOS anyway, such as gender, EuroSCORE II, elective status, and more complex types of procedures. This issue is important to examine more closely in future research, but ultimately if longer LOS is generally the only perioperative complication associated with in-hospital PMI after surgical ablation, then the impact may not be that critical. In our center, patients who are at risk for PMI are followed daily before the decision and this together with the delayed anticoagulation treatment is well reflected in LOS for these patients. The slight delay in the decision to proceed with PMI may be perceived by some as one of the main reasons for our lower rates of PMI. It is difficult to explain the PMI rate only by extended wait time in patients with bradycardia before the decision for implantation. In the CTSN study, the mean LOS was 13.2 AE 8.8 days for the ablation group and 12.4 AE 10.3 days for the control group, similar to the reported LOS for patients with PMI in our study. 15 We believe that if indeed our postoperative management has such an impact, it would be very important to conduct a controlled study to compare different schemes of postoperative care and decision-making. However, it is important to notice that if a longer wait before PMI had a true impact on the incidence of PMI it would be reflected in the rate of pacemaker dependency during follow-up. In the ABLATE trial, it was reported that approximately 40% of the patients were still in various degrees of pacemaker dependency after 18 months. 28 These rates somewhat resemble the data from our study.
In this study, we investigated the incidence of PMI following a full CM procedure in a relatively large number of patients. We found that the incidence of in-hospital PMI was relatively low, especially when compared with a recent CTSN study. 15 In our series, the vast majority of patients had PMI due to sinus node dysfunction and severe sinus bradycardia, whereas the CTSN study demonstrated relatively high incidence of AV block or delay as the primary indication. This observation is particularly noteworthy because when it comes to the right atrial lesion set and technique, it is especially important not to place additional lesions and avoid any unnecessary manipulations to the right atrial free wall. The concern when reviewing the CTSN study is that the study protocol allows an additional cavo isthmus line (flutter line) that is not part of the CM procedure and results in significant compartmentalization of the right atrium and conduction delays. 11, 15 It is also especially important to recognize that in our series, despite high rates of sinus rhythm in the early postoperative time frame, the incidence of PMI remained fairly low.
Sinus node dysfunction is associated with AF. [12] [13] [14] 29 The role of antiarrhythmic therapy before surgery is also worth investigation, as it may lead to a temporary sinus node dysfunction or severe bradycardia. The CM procedure should not result in primary sinus node dysfunction if careful application of the lesions is followed. In our study, the major indications for PMI were sick sinus syndrome, heart block, and sinus bradycardia, and more complex valve procedures were associated with greater likelihood of in-hospital PMI. A significant number of our patients were no longer pacemaker-dependent during follow-up (30%) and maintained sinus rhythm off AAD (71% at 2 years). This finding is not the first observation of such outcome, although our study was not specifically designed to follow the recovery of the sinus node and the autonomic nervous system. 30, 31 These studies also may suggest that procedures that are associated with higher success in ablating AF may reveal higher rates of sinus node dysfunction, as the heart is no longer allowed to fibrillate and generate heart rate. The concept of success in surgical ablation resulting in sinus node challenge should be investigated further.
CONCLUSIONS
One of the most important aspects of PMI following the CM procedure that was addressed in our study is the potential impact on patient outcome during both early and late follow-up. In our study, no such effect was discovered, including morbidity, mortality, rhythm status, and embolic events. PMI following the CM III/IV procedure was definitely associated with increased resource utilization; however, this should be reviewed carefully in the long-term as higher rates of sinus rhythm together with improved quality of life, reduced risk of stroke, and anticoagulation treatment and overall health-related cost. A careful examination into surgeon training and experience with the CM procedure, particularly during complicated concomitant procedures, may well help to improve rhythm outcomes and minimize adverse events, including in-hospital PMI.
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